Korian: Berenberg starts coverage with 'buy' rating
(CercleFinance.com) - German broker Berenberg has started its coverage of French care home operator Korian on Monday with a "buy" rating and a target price of 44 euros.
"The European dependent care market is supported by clear structural growth drivers, notably ageing populations and private care regimes," Berenberg said in a report on the sector.
Berenberg has also initiated coverage of Orpea, another French care home operator, with a "hold" rating and target price of 105 euros.
Korian shares are currently up 0.7% at 32.8 euros on Euronext Paris, while Orpea is down 0.5% at 103.6 euros.
Copyright (c) 2019 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
"The European dependent care market is supported by clear structural growth drivers, notably ageing populations and private care regimes," Berenberg said in a report on the sector.
Berenberg has also initiated coverage of Orpea, another French care home operator, with a "hold" rating and target price of 105 euros.
Korian shares are currently up 0.7% at 32.8 euros on Euronext Paris, while Orpea is down 0.5% at 103.6 euros.
Copyright (c) 2019 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.